We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

Arch Dermatol. 2012;148(2):157. doi:10.1001/archdermatol.2011.514.
Text Size: A A A
Published online


Each year, younger dermatologists replace aging practitioners, decreasing the availability of medical dermatologic care because younger physicians are more prone to engage in education, research, or cosmetics. An unmet demand for dermatologic care in the United States has led to greater use of physician extenders. Melanoma mortality may be predicted by factors such as physician specialty density, neighborhood racial heterogeneity, and median household income. In this analysis, Aneja et al demonstrate that within a given county, greater dermatologist density is associated with lower melanoma mortality rates compared with counties lacking dermatologists.

See Article


Hidradenitis suppurativa (HS) is characterized by nodular inflammatory lesions evolving into abscesses that are mainly located near apocrine glands. Current pathogenetic theories implicate hyperkeratosis of the follicular epithelium leading to apocrine gland occlusion, follicular rupture, inflammation, and secondary corynebacteria infection. In this prospective analysis, Dr éno et al demonstrate downregulation of innate immunity markers in HS skin, suggesting that deficient cutaneous innate immunity may play a crucial role in the development of HS. Three months of zinc treatment induced a significant increase in the expression of all the markers involved in innate immunity.

See Article


The clinical presentation of drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) is similar to that of non –DI-SCLE, with photodistributed nonscarring annular or papulosquamous lesions that may resolve after withdrawal of the causative drug treatment. The histopathologic finding of tissue eosinophils is typically not seen in SCLE. In this retrospective medical record review of patients with SCLE and prospective blinded histopathologic analysis, Hillesheim et al found no significant difference in the mean eosinophil ratios in the DI-SCLE vs non –DI-SCLE groups. Tissue eosinophilia is not a differentiating feature of DI-SCLE, and careful review of a patient's history in correlation with clinical findings remains the standard for identifying a drug as an etiologic factor in SCLE.

See Article


Infantile hemangiomas (IHs) are the most common benign tumors of infancy. They range from small localized papules to large, disfiguring and function-threatening tumors. The heterogeneity of IHs has been described by classification schema based on depth, morphologic characteristics, and clinical behavior. Given the wide heterogeneity of IHs, it is imperative to carefully assess the risk associated with an individual IH to guide clinical decision making. Haggstrom et al describe the Hemangioma Severity Scale (HSS) and the Hemangioma Dynamic Complication Scale (HDCS), which will allow detailed assessment of clinical outcome and standardization of hemangioma research.

See Article


Dystrophic epidermolysis bullosa (DEB) is a bullous genodermatosis caused by mutations in the type VII collagen gene. In revertant mosaicism, germline mutations are corrected by somatic events resulting in a mosaic disease distribution. This “natural gene therapy ” phenomenon has long been recognized in other forms of epidermolysis bullosa. In this case report, van den Akker et al describe a 21-year-old man with recessive DEB who reported an unaffected skin patch on his neck where blisters never occurred. In the unaffected skin, the somatic nucleotide substitution reverted the nonsense codon to tyrosine, thus restoring functional protein production. Cases such as this suggest promising therapeutic opportunities for the future.

See Article

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.